Avapecia Life Sciences Corp.

Avapecia is a biotechnology company engaged in the research, development, and commercialization of regenerative stem cell technologies and therapy solutions for use in hair loss prevention, maintenance, and hair regeneration as well as to address various medical conditions in female pelvic medicine. Using licensed, patented, and patent pending bioprocessing technology, Avapecia aims to restore lost hair or halt the progression of hair loss, in addition to addressing various medical conditions in female pelvic medicine, also known as urogynaecology, by isolating safe, high quality, viable, and potent stem cells from a patient’s own fat, or adipose tissue.